CFO Compensation in New York City, 2026

There is a question we get asked at least once a week, in some form: "what should a CFO be making in New York?" The candid response is that there is no single number, the range is more than four times from bottom to top, and most published benchmarks — the kind your HR partner shows you in a comp committee deck — are wrong by a factor of two depending on which kind of New York CFO role you’re benchmarking.

This analysis is grounded in 39 CFO placements we closed in the New York metropolitan area between January 2025 and the first week of April 2026. Each data point in this analysis comes from a verified, executed offer document for a professional who has since assumed the role. We’ve broken the data down by company stage, by industry, and by the specific components of the package — including the ones most candidates overlook in negotiation.

The landscape for senior finance leadership in New York is at a distinctive juncture currently. The traditional NYC CFO — the public-company finance leader running a billion-dollar balance sheet from a Park Avenue office — still exists, and still pays approximately what you’d expect them to pay. But around that traditional archetype, four other archetypes have surfaced, each with a structurally distinct remuneration structure and a structurally distinct risk profile. Understanding which archetype your next role sits in — or which archetype you want to sit in — matters more than understanding "the market" in any aggregate sense.

The top-line: a four-times range

Across all 39 NYC CFO placements in our 2025–2026 dataset, median total remuneration at grant was $985,000. The 25th percentile was $620,000. The 75th percentile was $1.85 million. The single highest total-comp offer in our entire dataset — a CFO joining a pre-IPO fintech with a Q1 2027 IPO timeline — was $3.85 million.

If you stop reading there, you have a useful but incomplete picture. The 4× range from bottom to top is the central insight. The median masks a structural divide between three or four very different kinds of CFO job that all happen to be located in New York. They are functionally three different professions paying three different markets, and a candidate’s job is less to "negotiate harder" within whatever market they happen to land in than it is to figure out, in advance, which of those markets they actually want to be in.

Before we go deeper, one definitional point. The phrase "CFO salary" is misleading in a way that matters. For a senior finance executive in New York, base salary is somewhere between 30% and 60% of total remuneration depending on the company type. Quoting just base, the way many recruiters and most published benchmarks do, is like describing a car by its weight — technically accurate, not very useful for the inquiry you’re actually asking. Throughout this piece we’ll discuss four components: base salary, target bonus (cash, paid annually based on performance), equity (RSUs, options, or carried interest valued at the time of grant), and sign-on (one-time, cash or stock, generally with a 12-month clawback). The fifth and most overlooked component is severance and change-of-control terms, which we’ll address in section 8.

The public-company CFO

Public-company CFO roles in New York divide into two practical buckets: mid-cap S&P 400 companies ($1B to $10B in market capitalization) and large-cap S&P 500 companies ($10B and above). We completed placements for 12 public-company CFOs in 2025–2026, split approximately evenly between these two buckets, and the structure of their remuneration packages is the most foreseeable in our entire dataset.

For mid-cap public companies, the package looks approximately like this. Base salary anchored at $400,000 to $500,000. Annual bonus targeted at 75% to 100% of base salary, paid in cash, with payout determined by a combination of company financial metrics and discretionary CEO assessment. Long-term equity is generally a mix of time-vesting RSUs (usually a 3-year cliff or 4-year graded schedule) and performance-vesting PSUs tied to total shareholder return, return on equity, or specific operational metrics. The grant-date value of annual equity ranges $350,000 to $550,000. Median total remuneration at grant for a mid-cap public CFO in our 2025 NYC dataset: $1.15 million.

For large-cap public companies the numbers scale up, but the structure is similar. Base salaries of $475,000 to $575,000. Annual bonus targeted at 100% of base or more. Equity grants of $600,000 to $900,000 per year, with a conspicuously heavier PSU component — often 50% to 60% of the package is performance-vesting. The rationale for the PSU emphasis is straightforward: large-cap public boards face the most direct shareholder pressure on executive comp, and PSUs are the cleanest way to make the package look pay-for-performance to a proxy advisor. Median total remuneration at grant for a large-cap public CFO: $1.70 million.

A figure in that table is worth examining closely. Severance at the public-company CFO level is now reliably 17 to 24 months for mid-cap and 24 to 36 months for large-cap, plus full vesting acceleration on change of control. Half a decade ago, those numbers were 12 months and 17 months respectively. The transition mirrors two related trends: a more active M&A environment among large public companies, where a CFO might be displaced by an acquirer’s preferred candidate; and the growing recognition by boards that recruiting top CFOs requires considerable downside protection. If you are negotiating a public-company CFO offer in New York and the severance term offered is shorter than 17 months, you have leverage. We have moved this term in nearly every public-company offer we have negotiated in the past 17 months.

The PE-backed CFO

The most conspicuous remuneration structure in our 2025 dataset, by a considerable margin, is the PE-backed CFO. We completed placements for 17 of these in New York — the largest single sub-segment of our CFO dataset — and the structure looks structurally distinct from the public-company role.

Base salaries are conspicuously lower than public-company peers. Median was $385,000, with a range from $335,000 at smaller Buyout 1.0-style platform companies to about $475,000 at larger platforms or scaled portfolio companies. The rationale for the lower base is that the potential gain is concentrated in carried interest on the sponsor’s eventual exit, or in sweet equity — a CFO-specific equity grant outside the management equity plan that vests on liquidity. The CFO is, structurally, an investor in the deal alongside the sponsor; they take a lower base in exchange for that investor-aligned upside.

A typical PE-backed CFO package at a Buyout 1.0 or Buyout 2.0 portfolio company in 2025 looks something like the following:

• Base salary: $350,000 to $425,000
• Target bonus: 50% to 70% of base, paid annually based on company EBITDA performance
• Co-invest opportunity: $250,000 to $1 million, on the same terms as the sponsor (this is the CFO writing a personal check)
• Sweet equity grant: 0.5% to 2.0% of the deal — cliff vesting at exit, with intermediate liquidity if a recapitalization occurs
• Sign-on bonus: $75,000 to $250,000, calibrated to whatever the candidate is forfeiting at their current employer
• Severance: generally 12 months base, sometimes with a "material adverse event" clause that protects against fire-sale exits

The calculus on the sweet-equity component is what determines whether a PE-backed CFO role is a good deal. Take a portfolio company acquired by a sponsor at a $500 million enterprise value, financed at 50% equity ($250 million) and 50% debt. A 1% sweet equity grant for the CFO has a face value of $2.5 million at the deal’s entry valuation. If the company exits five years later at $1.2 billion enterprise value with the debt paid down, the equity value at exit is approximately $1.0 billion. The CFO’s 1% has expanded to $10 million — minus tax on the carried-interest portion, minus the candidate’s original co-invest if they participated. After tax, on a successful exit, that’s perhaps $7 million of cash to the CFO over the five-year hold.

The counterpoint: if the company doesn’t exit profitably, the sweet equity is worth nothing. We have placed several CFOs in 2018–2020 vintage deals whose portfolio companies are still in the sponsor’s portfolio in 2026, with no realized exit. The base salaries they took were 30% below market for the equivalent public role. The equity they were granted is paper. They have given up, in cash remuneration terms, five-plus years of public-company comp. It works out for many; it doesn’t work out for some.

A frequently overlooked structural detail at the PE-backed CFO level: the "good leaver / bad leaver" mechanics that determine what happens to vested equity if you leave before exit. Most PE management equity plans treat a CFO who resigns voluntarily as a "bad leaver" — meaning the vested equity is purchased back by the company at original cost basis, not at fair market value. This is a structural protection for the sponsor but a tangible risk for the CFO who needs or wants to leave before exit. Negotiating "good leaver" treatment for specific scenarios (medical, change of control, executive constructive termination) is something we advocate for in nearly every PE-backed CFO offer. It costs the sponsor essentially nothing if the conditions don’t trigger; it may be worth millions to the CFO if they do.

The pre-IPO CFO

The highest-variance bucket in our 2025 NYC dataset. We completed placements for 11 CFOs at pre-IPO companies between January 2025 and April 2026, and the dispersion of total remuneration among those 11 is wider than within any other segment we address. The single highest total-comp number in our entire dataset came from this category: a CFO joining a fintech preparing for a 2027 IPO, with $3.85 million in total remuneration at grant.

That number, alone, is misleading. At a pre-IPO company, the equity portion of the package is valued at the most recent 409A — which is generally well below the implied valuation of the most recent venture round (often 30% to 50% below by design, for tax reasons). The "real" expected value of pre-IPO equity is impossible to know with certainty until either an IPO or a tender offer produces a price-discovery event. A $1.5 million grant at a 409A might be worth $5 million at a fair-market valuation today, and could be worth zero in three years if the company never IPOs or sells.

The composition by stage in our 2025–2026 dataset:

• Series B/C (pre-Series-D, generally $50M–$200M raised): Base $290,000 to $340,000; bonus 25% to 40% of base; equity grant 0.4% to 0.8% of fully diluted shares (at 409A, often $600K to $1.14M; at last-round valuation, often 3–5x that)
• Series D/E (generally $200M+ raised, IPO 12 to 36 months out): Base $340,000 to $390,000; bonus 30% to 50%; equity 0.2% to 0.4% (generally $1.43M to $3.5M at 409A)
• Late pre-IPO (S-1 filed or imminent): Base $400,000 and up; bonus 50%+; equity grants more conservative on percentage basis (~0.15% to 0.3%), but with imminent liquidity and clearer valuation

The pre-IPO CFO is, based on our observations, the most distinct of the NYC CFO archetypes. The job itself is also authentically different from the public-company or PE-backed CFO role. A pre-IPO CFO is often doing a considerable portion of investor relations, IPO preparation, audit committee establishment, and SOX-readiness work that simply doesn’t exist at established public companies (already done) or at PE-backed companies (generally not relevant). The role is functionally a hybrid of CFO and Chief Operating Officer in many cases, and the candidates who succeed in it are generally those who have both finance depth and a tolerance for operational chaos.

Industry mix within New York

Beyond company stage, the industry of the company materially shapes both the package and the candidate experience. The composition of NYC CFO demand has evolved markedly across the preceding three years. Half a decade ago, the overwhelming majority of our NYC CFO searches were for traditional financial services firms — asset managers, banks, insurance companies, REITs. Today the mix is authentically more diverse, and the dispersion of packages across industries is wide.

A few observations from that table that aren’t obvious at first glance.

FinTech and payments now pays more than traditional financial services. The median FinTech CFO total comp ($1.57M) is considerably above the median traditional FS CFO total comp ($1.38M) for what is, in many cases, a smaller balance sheet and a less complex regulatory environment. This is the equity premium at work — FinTech CFO packages are regularly 50% equity by value, often vesting on a 4-year schedule with considerable refresh grants. Traditional financial services CFO packages remain heavier in cash bonus and lighter in equity, partly because public-company equity grants are constrained by proxy advisor guidance.

Consumer/DTC and Real Estate/PropTech have declined sharply. These two segments combined were 22% of our 2021 CFO placements and just 13% of 2025. Both mirror the wider capital markets shift away from consumer-DTC and PropTech, which are out of fashion with venture capital and underperforming in public markets. We have encountered express conversations with consumer-DTC company boards in 2025 about their remuneration philosophy, and the universal message was: we can’t pay what we used to. CFO candidates with consumer specialization can anticipate packages 25% to 40% below their tech or finance peers for comparable scope.

Healthcare and digital health is growing faster than headcount, slower than capital. The number of NYC healthcare CFO placements grew 80% from 2021 to 2025, but the median total remuneration grew only 9% over the same period. The reading: capital is flowing into health-adjacent companies, but it’s concentrated in a small number of well-funded firms, with many of the remaining firms operating on thinner budgets that constrain CFO packages.

The equity structure beneath the number

The top-line remuneration number tells you what the package is worth at grant. The structure of the equity within that number tells you what the package is likely to be worth at vest. Two CFO offers can have identical $1.5 million headline totals and produce realized comp outcomes that differ by $800,000 over a 4-year horizon. The structure is where the true money is.

Five architectural factors matter most.

First, vesting schedule. The traditional 4-year cliff (1-year cliff at start, then monthly vesting through year four) is being replaced at many late-stage tech firms and AI-native companies with shorter, front-loaded schedules. We completed placements for three CFOs in 2025 with 3-year vesting and one with front-loaded vesting (33% year one, 33% year two, balance year three). Shorter vesting schedules favor the candidate — if the company succeeds, the equity is realized sooner; if the company struggles, you’re less locked in. Longer vesting schedules favor the company by creating retention. This is a considerable negotiation lever, often more considerable than the top-line grant size.

Second, refresh policy. At public companies, annual refresh grants are standard. At late-stage private companies, refreshes are negotiable but increasingly common. At PE-backed and early-stage companies, refreshes are uncommon, and what you get at signing is generally what you get for the duration. If the offer letter is silent on refresh, ask expressly. A guaranteed minimum refresh of $400,000 per year for years two through four adds $1.2 million to your expected total remuneration over a 4-year horizon.

Third, acceleration on change of control. What happens to your unvested equity if the company is acquired? Three structures: single-trigger (full vesting acceleration on change of control alone, regardless of whether you stay or leave) is the strongest candidate position. Double-trigger (acceleration only if change of control occurs and you are terminated without cause within 12 to 24 months) is the most prevalent compromise. No acceleration is the company default. The expense to the company of agreeing to double-trigger acceleration is essentially zero in any normal scenario; the benefit to the candidate in an exit scenario may be considerable.

Fourth, tax indemnification on equity. Particularly important for IPO equity where you may owe income tax on shares you cannot yet sell because of lock-up restrictions. Major companies sometimes offer tax indemnification or cash gross-ups for this exposure. If your equity grant has tax exposure in a year you can’t sell, ask for indemnification. If they refuse, factor the post-tax cost into your evaluation of the package.

Fifth, equity vesting on resignation for good reason. "Good reason" is the legal term for a resignation that ought to be treated like a termination without cause — generally triggered by material reduction in role, remuneration, or geographic relocation. Without good-reason provisions, severance and acceleration only protect you if the company fires you. With them, they protect you if your job materially changes after you accept. This is the foremost overlooked clause in CFO offer letters based on our observations.

Six components most candidates miss

Base, bonus, equity, and sign-on cover most of the discussion in a typical CFO offer negotiation. There are six other components that materially affect the worth of the package and are regularly overlooked. We negotiate on all of these as a matter of process.

1. Severance length and "good reason" triggers. Most candidates negotiate severance length but forget to negotiate the triggers. Without a comprehensive good-reason definition, severance applies only if you’re fired without cause — not if you resign because the role materially changed. Advocate for 18+ months of severance and a comprehensive good-reason clause that includes considerable reduction in scope, change in reporting relationship, geographic relocation, and material reduction in remuneration.
2. D&O insurance and Section 16 indemnification. Standard for public-company CFOs, but worth confirming expressly. For private-company CFOs, this is often missing or limited and worth pushing for. An indemnification clause covering legal defense costs in shareholder, regulatory, or governmental actions is considerable protection in a job that occasionally generates lawsuits.
3. Carried interest tax treatment at PE-backed companies. The carry ought to be structured as long-term capital gains, not ordinary income. The structuring is technical but regularly sloppy. Make sure your tax advisor reviews the equity documents before signing. The tax rate difference between ordinary-income and long-term-capital-gains treatment may be 17 to 20 percentage points.
4. Equity refresh policy. If the offer is silent, ask. Document the response in the offer letter, not in a verbal commitment. Annual refreshes are standard at public companies and increasingly common at late-stage private. The cumulative value of refresh grants over a 4-year tenure generally exceeds the initial grant.
5. Sign-on with clawback terms. Sign-on bonuses generally carry a 12-month clawback (you repay the full amount if you leave within 12 months). Some have longer clawbacks — we have observed 24- and 36-month structures. The longer the clawback, the more constrained you are. Negotiate the clawback terms, not just the dollar amount.
6. Relocation package, even if you’re already in NYC. Many CFOs neglect to negotiate a relocation package because they’re already in market. But "relocation" may be defined broadly — temporary housing during a transition, moving expenses for a household move within the metro, real-estate transaction costs if the role requires a move closer to a new office, even commuter expense reimbursement. We have negotiated $50,000 to $200,000 of relocation-categorized payments for CFOs who didn’t move at all.

The counter-offer trap, in particular for CFOs

A note on something that comes up in approximately half of our active CFO searches: the counter-offer from the candidate’s current employer. The general data on counter-offers is unambiguous — 73% of candidates who accept counter-offers leave anyway within 17 months, often involuntarily, and the next role is generally worse than the offer they declined. We’ve written about this elsewhere in detail.

For CFOs in particular, the dynamics are sharper, and a few sub-patterns are worth observing.

The CFO counter-offer almost always misses on equity. Most CFO counter-offers are cash — a base bump, a retention bonus, or both. They rarely include incremental equity, because the present employer’s equity comp committee can’t move quickly enough to approve a discretionary refresh outside the annual cycle. This means the counter, even when it’s cash-contested with the new offer, almost always lags the new offer on the equity component — which, as we’ve discussed, is generally the largest component of total comp.

The CFO counter-offer reveals what the company will pay under pressure, not what they were willing to pay otherwise. Almost every CFO who receives a credible counter has the same realization in the conversation: the company has had every annual cycle to pay them what they’re now offering, and they chose not to. The counter doesn’t mirror recognition; it mirrors expediency in the face of a costly replacement.

The CFO counter-offer creates uncomfortable visibility with the audit committee. A CFO is, by the nature of the role, in regular contact with the audit committee and the board. A CFO who threatened to leave and was talked back is now a CFO the audit committee knows was on the verge of leaving. Future conversations about strategic decisions, succession planning, and the CFO’s role in any transaction are colored by that fact. Several CFOs in our follow-up dataset described this dynamic in identical terms: "I never had the same standing in the boardroom after that."

Where the leverage actually lives

If you’re negotiating a CFO offer in New York, the highest-leverage areas based on our observations are, in order:

Equity at grant. The single largest negotiable component of most CFO packages. We have increased equity grants by 25% to 50% in negotiation more often than any other component. The rationale: equity grants are sized by HR teams using internal benchmarks that are often dated, and the comp committee has discretion to approve above-benchmark grants for the right candidate. Asking for a higher equity grant expressly, with comparable peer data, succeeds far more often than it fails.

Sign-on. Especially effective when you have unvested equity at your current employer. Document the make-whole calculation in particular — how much unvested equity, what vesting schedule, what current valuation — and most companies will match the cash value. The sign-on is the most flexible single component of an offer because it doesn’t require sustained budget commitment.

Severance length and good-reason triggers. Cheap for the company to grant in expectation, valuable for you in realization. We advocate for 18+ months of severance with a comprehensive good-reason clause in every public-company CFO negotiation. The clause costs the company nothing if you stay; it may be worth $1 million to you if you don’t.

Equity acceleration on change of control. Particularly important if the company you’re joining is at all a candidate for being acquired in your tenure. Single-trigger acceleration is the strongest position; double-trigger is the most prevalent compromise. The expense to the company in any non-exit scenario is zero; the worth to you in an exit scenario may be $2 million or more.

Title and reporting line. This isn’t comp directly, but it shapes future comp. A CFO who reports to the CEO is paid differently from a CFO who reports to the COO or the President. A "Chief Financial Officer and Treasurer" is paid differently from just "Chief Financial Officer." If you can negotiate the reporting line up or the title scope wider, the comp follows over time.

What we’re seeing in 2026 versus prior years

Three developments in our 2025 and Q1 2026 placements that are markedly different from 2023–2024.

First, equity is taking a larger share of the package, particularly at PE-backed and pre-IPO companies. In our 2021 NYC CFO dataset, equity was approximately 35% of median total comp. In our 2025 dataset, equity is approximately 48% of median total comp. The transition mirrors both more aggressive equity grants and somewhat constrained cash budgets at many companies. For candidates, this means more upside in the success case and more risk in the failure case. The risk-adjusted view of the package matters more than the top-line.

Second, retention bonuses are appearing as a distinct package component. In our 2024 dataset, retention bonuses (cash bonuses tied to staying for a particular period beyond the standard sign-on clawback) appeared in 4% of CFO offers. In 2025 they appeared in 17%. The retention bonus is the company’s response to the increased contested intensity in the senior finance market — an express attempt to lock in the CFO beyond the normal 12-month sign-on clawback period.

Third, the differential between the highest and lowest packages within the same role profile has broadened. Our 2021 NYC CFO dataset had a 75th-to-25th-percentile ratio of about 2.4x. Our 2025 dataset has the same ratio at 3.0x. This is consistent with the wider bifurcation in senior US remuneration we documented in our 2026 Executive Remuneration Report, and it has practical implications for candidates. The same résumé, going into the market for the same kind of role, will receive offers that range more widely than they might have three years ago. The marginal value of a well-run search process has gone up.

How to benchmark yourself honestly

Most candidates underestimate the differential between what they currently earn and what their next role would pay. This is normal — the comp at your current role was adjusted incrementally over years, and you don’t see the cumulative drift from market. Three practical exercises if you want to benchmark yourself.

Identify your archetype first. Public-company CFO, PE-backed CFO, or pre-IPO CFO are three different markets. Pick which one you’re currently in and which one you want to be in. If those are different, the move you ought to be planning is between archetypes, not just within one.

Anchor to total comp at grant, not base or "what you make." "What I make" is a casual conversational frame; total comp at grant is the right professional frame. Most CFOs we talk to who say "I make $500,000" are actually earning $700,000 to $900,000 when equity vesting and bonus payout are properly counted. Knowing the right number reduces the chance of accepting an offer that looks like a raise but is actually a step backward.

Get a second opinion before accepting. Approximately half of the CFO candidates we work with come to us in the final stages of an active offer, not at the start of a search. They want to know whether the offer they have is contested. We’re happy to give that read — the discussion is private, complimentary, and productive regardless of whether we end up working together. If you’d like a benchmark read on a current offer or your current comp against our 2025–2026 dataset, send a message to margot.sinclair@emersonsearch.com directly or use the general contact form.

Methodology & caveats

This analysis is derived from 39 verified, finalized and countersigned offer documents from CFO placements in the New York metropolitan area made by Emerson Search between January 2025 and the first week of April 2026. We exclude offers that were extended but rejected, withdrawn, or never finalized. "New York metropolitan area" includes Manhattan, the immediate boroughs of New York City, Westchester County, and the New Jersey commute zone within 30 miles of Midtown.

All remuneration figures are gross (pre-tax), in nominal US dollars. Equity is valued at grant using the company’s most recent 409A valuation for private companies and the trailing 30-day average closing price for public companies. Target bonuses are reported at target, not actual payout. Sign-on bonuses are reported as full one-time amounts. Severance terms are reported as the contractual maximum negotiated.

For complete methodology including assumptions around company stage classification, equity valuation methodology, and how we handled cross-segment outliers, see the methodology appendix to our 2026 Executive Remuneration Report.

This report does not constitute legal, financial, or remuneration advice. Specific remuneration outcomes vary based on candidate qualifications, company budget constraints, role scope, and market conditions at the time of negotiation. For questions about the data or to request the anonymized dataset for academic or research use, contact research@emersonsearch.com.

This piece is authored by Margot Sinclair, Talent Partner for our Finance & Capital Markets practice, with data assembly and review by the Emerson Search research team. Margot leads our New York finance executive search practice from our headquarters at 110 East 42nd Street, Suite 1400. Direct contact: margot.sinclair@emersonsearch.com.